In androgen-sensitive LNCaP prostate cancer cells, immunoprecipitation of endogenous AR after DHT treatment or Ack1 expression demonstrated that association between AR and SLIRP is inhibited by DHT or Ack1 activation (Fig. 1C). This evidence concerns the gene AR and prostate cancer.